Digiceuticals include Digital therapeutic products and these products represent a completely new era of healthcare industry. These products are clinically certified and are sued as either standalone products or are linked to other products to improve and benefit health outcomes.
Digiceuticals is used in various apps which are approved by regulatory bodies. These products are used to treat various disease conditions like diabetes management. Digiceuticals platform works by collation of data by survey like asking the patients. The information is sometimes gathered by sensors also.The products are clinically tested through randomized trials.
Some of the common examples of Digiceuticals are apps for diabetes where symptoms are monitored, cessation of smoking apps where there is a sensor that checks breathing and also guide on quitting smoking. The substance abuse apps in Digiceuticals work via behavioral therapies.
Digiceuticals apps help patients to daily monitor their triggers and symptoms and track those with the doctors. Digiceutical apps provide real time support and coaching to the patients. Digiceutical also provides personalized educational tools. The patients receive personal training and expert guidance that helps to increase health outcomes.
Digiceuticals market: Drivers and restraints
Digiceuticals are seeking intensive attention by the world. Around 150 companies are in development of Digiceuticals. This rising investment in research and development of Digiceuticals worldwide is a major driving force for its market growth.
Many disease conditions are being tested via Digiceuticals which include depression, insomnia, chronic pain, anxiety etc. Digiceuticals covers a wide range of diseases and this can be a factor to outlook its growth in coming years. Gaining popularity of Digiceuticals in the techno savy world is a major driver for Digiceuticals market.
Companies are rigorously investing in clinical trials The rising adoption of Digiceuticals over conventional treatment in regions like the US and UK can definitely upswing the Digiceuticals market.
Theses apps have shown to improve the lives of asthma patients. It is anticipate that Digiceuticals will be rapidly growing with innovations. Lack of data to prove efficacy in randomized trails is a major restraint of the Digiceuticals market.
Lack of awareness about usage of smart phones and apps in aging population across lower economic countries can restrict the Digiceuticals market growth. Irresponsive behavior patients in not using the app regularly can deviate the correct data.
Digiceuticals Market: Overview
Digiceuticals market focuses on assessing the impact and value of digital therapeutics. App developers are finding it easy to enter the field of Digiceuticals market compared to traditional pharma entrants.
Lot of Digiceuticals companies are directly working with payers, healthcare suppliers, academic and research institutes and pharmaceutical industries to understand data driven combination and usage in all sectors of the healthcare.
Digital health is rapidly growing worldwide. It is also predicted that technology and Digiceuticals will be replacing 80% of the doctor’s work in coming years. Many Digiceuticals companies also provide one on one sessions with healthcare experts. Akili Labs are in development of patenting a digital mode to measure interference processing.
Digiceuticals Market: Region wise outlook
The US is a leader in Digiceuticals market. In 2018 US was working on development of anti-cocaine and alcohol addiction Digiceuticals. In the US, Digital Therapeutics alliance works on representing leading manufacturers of clinically approved digital therapeutics.
Increasing in understanding of Digiceuticals in mainstream healthcare professionals and broadening research is an opportunistic feature for Digiceutical market. It is estimated that around 22% of patients show interest in Digiceuticals for disease management. And around 44% of doctors in the US prescribe for Digiceuticals apps.
Digiceuticals key Market players:
The key participants operating in the global Digiceuticals market are:
- Pear therapeutics Inc
- Akili Interactive Labs, Inc
- Propeller helath
- Chrono Therapeutics Inc.
The research report on Digiceuticals presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report on Digiceuticals provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Digiceuticals market: Segmentation
The global Digiceuticals market is segmented based on the receptor type, application in cancer type, therapy type, drug type, therapy type, drug development status, clinical trial recruitment status, end user and region.
- Smart phone
- Medical device system
- Diabetes management
- Substance abuse
- Pulmonary diseases
- Alcohol and smoking addiction
- Neurological disorders
By distribution channel
- Specialty clinics
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.